Form 4: Voyager Therapeutics Executive Sells Shares to Cover Tax Obligations

Toby Ferguson, Chief Medical Officer of Voyager Therapeutics, sold 10,086 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• On April 2, 2025, Toby Ferguson, the Chief Medical Officer of Voyager Therapeutics, sold 10,086 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units on April 1, 2025.
• The shares were sold at a weighted average price of $3.43, with individual transactions ranging from $3.35 to $3.51.
• Following the transaction, Ferguson directly owns 157,914 shares of Voyager Therapeutics.
• The sale was not a discretionary trade but rather an automatic sell-to-cover election.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sell-to-cover) for tax purposes, which is neither particularly positive nor negative. The sentiment is neutral.

Industry Context

Sales by company executives are a normal part of corporate governance. This sale appears to be for tax obligations and not a reflection on the company's prospects.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.

Key Dates

Keywords

Voyager Therapeutics, Toby Ferguson, stock sale, Form 4, insider trading, restricted stock units, tax obligations, VYGR